Disclosure: This article does not represent investment advice. The content and materials presented on this page are for educational purposes only.
2024 is off to a good start. It’s a good start to what many believe will be a bull market. Although some tokens got a head start, cryptocurrency experts expect the price of XRP to surge. This is due to poor performance in the fourth quarter of 2023. Meanwhile, traders are bullish on Injective (INJ) and InQubeta (QUBE).
In this post, we will cover the expected XRP price surge and optimism about Injective and InQubeta.
InQubeta approach
InQubeta is a low-market capitalization project that has raised over $7.9 million in seed funding.
It sits at the intersection of two of the world’s most transformative innovations: AI and blockchain.
The unique approach will introduce a new funding approach to the AI sector.
InQubeta aims to be a crowdfunding platform for AI startups. Additionally, the NFT Marketplace will become a hub for proven AI projects or early-stage companies.
In presale level 6, you can purchase QUBE for $0.01925. Experts say there could be more upside once the token is launched.
Is an XRP Rally Coming?
After Ripple and XRP made headlines in mid-2023, their prices plummeted.
However, analysts expect prices to recover despite disappointing performance in the second half of 2023.
Preparing for Injections for Benefits
Injective has been one of the highlights of 2023 after posting a sharp rally.
Analysts expect INJ bulls to extend their gains.
Injective is committed to finance powering the next generation of DeFi applications, in which INJ will play a key role.
conclusion
Analysts expect cryptocurrency prices to rebound in 2024. Cryptocurrency experts say XRP will surge, but traders are investing in Injective and InQubeta to outperform the market.
Disclosure: This content is provided by a third party. crypto.news does not endorse any products mentioned on this page. Users must conduct their own investigation before taking any action related to the Company.